4.7 Article

Heterogeneities in Cell Cycle Checkpoint Activation Following Doxorubicin Treatment Reveal Targetable Vulnerabilities in TP53 Mutated Ultra High-Risk Neuroblastoma Cell Lines

Journal

Publisher

MDPI
DOI: 10.3390/ijms22073664

Keywords

ATM; cell cycle arrest; DNA damage; drug-resistance; high-risk neuroblastoma; mitotic-arrest; p21; proliferation

Funding

  1. Barncancerfonden [NCP2016-0009, PR2017-0059, TJ2019-0118, TJ2019-0072, PR2019-0101]
  2. Radiumhemmets forskningsfonder [171241]
  3. Stiftelsen AnnaBrita o Bo Casters Minne
  4. Eva and Oscar Ahren Foundation, Stockholm
  5. Karolinska Institutet [2-2109/2019-18]
  6. Region Stockholm (ALF) [K2892-2016]
  7. Magnus Bergvalls stiftelse

Ask authors/readers for more resources

In this study, a comprehensive analysis of cell cycle checkpoint activation following doxorubicin treatment was conducted in TP53 mutated ultra high-risk neuroblastoma cell lines, revealing distinct cell cycle checkpoints and potential druggable targets. The results showed dose-dependent accumulation in S- and/or G2/M-phase, as well as heterogeneous increase of cell cycle checkpoint proteins among the cell lines. Combination treatment with doxo and a small-molecule ATM inhibitor delayed regrowth in specific cell lines, indicating checkpoint dependent and independent targets.
Most chemotherapeutics target DNA integrity and thereby trigger tumour cell death through activation of DNA damage responses that are tightly coupled to the cell cycle. Disturbances in cell cycle regulation can therefore lead to treatment resistance. Here, a comprehensive analysis of cell cycle checkpoint activation following doxorubicin (doxo) treatment was performed using flow cytometry, immunofluorescence and live-cell imaging in a panel of TP53 mutated ultra high-risk neuroblastoma (NB) cell lines, SK-N-DZ, Kelly, SK-N-AS, SK-N-FI, and BE(2)-C. Following treatment, a dose-dependent accumulation in either S- and/or G2/M-phase was observed. This coincided with a heterogeneous increase of cell cycle checkpoint proteins, i.e., phos-ATM, phos-CHK1, phos-CHK2, Wee1, p21(Cip1/Waf1), and p27(Kip) among the cell lines. Combination treatment with doxo and a small-molecule inhibitor of ATM showed a delay in regrowth in SK-N-DZ, of CHK1 in BE(2)-C, of Wee1 in SK-N-FI and BE(2)-C, and of p21 in Kelly and BE(2)-C. Further investigation revealed, in all tested cell lines, a subset of cells arrested in mitosis, indicating independence on the intra-S- and/or G2/M-checkpoints. Taken together, we mapped distinct cell cycle checkpoints in ultra high-risk NB cell lines and identified checkpoint dependent and independent druggable targets.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available